ETFMG Treatments Testing and Advancements ETF (GERM)
GERM is a passive ETF by ETFMG tracking the investment results of the Prime Treatments, Testing and Advancements Index. GERM launched on Jun 17, 2020 and has a 0.68% expense ratio.
ETF Info
| ISIN | US26924G7631 |
|---|---|
| CUSIP | 26924G763 |
| Issuer | ETFMG |
| Inception Date | Jun 17, 2020 |
| Region | North America (U.S.) |
| Category | All Cap Equities |
| Index Tracked | Prime Treatments, Testing and Advancements Index |
| Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Blend |
Expense Ratio
The ETFMG Treatments Testing and Advancements ETF has a high expense ratio of 0.68%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in ETFMG Treatments Testing and Advancements ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
ETFMG Treatments Testing and Advancements ETF had a return of -13.33% year-to-date (YTD) and -16.26% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -13.33% | 6.92% |
| 1 month | -8.25% | -2.83% |
| 6 months | 7.84% | 23.86% |
| 1 year | -16.26% | 23.33% |
| 5 years (annualized) | N/A | 11.66% |
| 10 years (annualized) | N/A | 10.52% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -5.58% | -0.27% | 0.25% | |||||||||
| 2023 | -7.26% | -10.15% | 9.66% | 11.23% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
ETFMG Treatments Testing and Advancements ETF(GERM)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for ETFMG Treatments Testing and Advancements ETF (GERM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
ETFMG Treatments Testing and Advancements ETF granted a 1.23% dividend yield in the last twelve months. The annual payout for that period amounted to $0.21 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Dividend | $0.21 | $0.24 | $0.14 | $0.10 | $0.29 |
Dividend yield | 1.23% | 1.24% | 0.62% | 0.28% | 0.92% |
Monthly Dividends
The table displays the monthly dividend distributions for ETFMG Treatments Testing and Advancements ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.06 | |||||||||
| 2023 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.05 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.03 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.29 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the ETFMG Treatments Testing and Advancements ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the ETFMG Treatments Testing and Advancements ETF was 64.81%, occurring on Oct 27, 2023. The portfolio has not yet recovered.
The current ETFMG Treatments Testing and Advancements ETF drawdown is 62.05%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -64.81% | Aug 10, 2021 | 559 | Oct 27, 2023 | — | — | — |
| -27.37% | Jul 23, 2020 | 33 | Sep 8, 2020 | 63 | Dec 7, 2020 | 96 |
| -23.96% | Feb 9, 2021 | 19 | Mar 8, 2021 | 104 | Aug 4, 2021 | 123 |
| -9.88% | Dec 9, 2020 | 16 | Dec 31, 2020 | 7 | Jan 12, 2021 | 23 |
| -3.58% | Jan 27, 2021 | 2 | Jan 28, 2021 | 1 | Jan 29, 2021 | 3 |
Volatility
Volatility Chart
The current ETFMG Treatments Testing and Advancements ETF volatility is 6.45%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.